Loading...

Immune checkpoint inhibitors in small cell lung cancer

Small cell lung cancer (SCLC) is a rapidly progressive cancer that often debilitates patients within months of detection and quickly becomes refractory to the limited options of therapy. While SCLC is not generally considered an immunogenic tumor, clinical experience suggests that patients with robu...

Full description

Saved in:
Bibliographic Details
Published in:J Thorac Dis
Main Authors: Pakkala, Suchita, Owonikoko, Taofeek K.
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2018
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861263/
https://ncbi.nlm.nih.gov/pubmed/29593891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.51
Tags: Add Tag
No Tags, Be the first to tag this record!